220 related articles for article (PubMed ID: 8255444)
1. Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies.
Mathews PM; Andermann F; Silver K; Karpati G; Arnold DL
Neurology; 1993 Dec; 43(12):2484-90. PubMed ID: 8255444
[TBL] [Abstract][Full Text] [Related]
2. Autopsied case with MERRF/MELAS overlap syndrome accompanied by stroke-like episodes localized to the precentral gyrus.
Miyahara H; Matsumoto S; Mokuno K; Dei R; Akagi A; Mimuro M; Iwasaki Y; Yoshida M
Neuropathology; 2019 Jun; 39(3):212-217. PubMed ID: 30972844
[TBL] [Abstract][Full Text] [Related]
3. Metabolic abnormality in acute stroke-like lesion and its relationship with focal cerebral blood flow in patients with MELAS: Evidence from proton MR spectroscopy and arterial spin labeling.
Wang R; Hu B; Sun C; Geng D; Lin J; Li Y
Mitochondrion; 2021 Jul; 59():276-282. PubMed ID: 34186261
[TBL] [Abstract][Full Text] [Related]
4. Characteristic cardiac phenotypes are detected by cardiovascular magnetic resonance in patients with different clinical phenotypes and genotypes of mitochondrial myopathy.
Florian A; Ludwig A; Stubbe-Dräger B; Boentert M; Young P; Waltenberger J; Rösch S; Sechtem U; Yilmaz A
J Cardiovasc Magn Reson; 2015 May; 17(1):40. PubMed ID: 26001801
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial dysfunction and cerebral metabolic abnormalities in patients with mitochondrial encephalomyopathy subtypes: Evidence from proton MR spectroscopy and muscle biopsy.
Niu FN; Meng HL; Chang LL; Wu HY; Li WP; Liu RY; Wang HT; Zhang B; Xu Y
CNS Neurosci Ther; 2017 Aug; 23(8):686-697. PubMed ID: 28695670
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial disorders: analysis of their clinical and imaging characteristics.
Barkovich AJ; Good WV; Koch TK; Berg BO
AJNR Am J Neuroradiol; 1993; 14(5):1119-37. PubMed ID: 8237691
[TBL] [Abstract][Full Text] [Related]
7. Cerebral metabolic abnormalities in A3243G mitochondrial DNA mutation carriers.
Weiduschat N; Kaufmann P; Mao X; Engelstad KM; Hinton V; DiMauro S; De Vivo D; Shungu D
Neurology; 2014 Mar; 82(9):798-805. PubMed ID: 24477106
[TBL] [Abstract][Full Text] [Related]
8. Reversible decreases in N-acetylaspartate after acute brain injury.
De Stefano N; Matthews PM; Arnold DL
Magn Reson Med; 1995 Nov; 34(5):721-7. PubMed ID: 8544693
[TBL] [Abstract][Full Text] [Related]
9. SPECT findings in mitochondrial encephalomyopathy.
Watanabe Y; Hashikawa K; Moriwaki H; Oku N; Seike Y; Kodaka R; Ono J; Uehara T; Kusuoka H; Nishimura T
J Nucl Med; 1998 Jun; 39(6):961-4. PubMed ID: 9627326
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis.
De Stefano N; Dotti MT; Mortilla M; Federico A
Brain; 2001 Jan; 124(Pt 1):121-31. PubMed ID: 11133792
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted image and MR spectroscopic analysis of a case of MELAS with repeated attacks.
Kim HS; Kim DI; Lee BI; Jeong EK; Choi C; Lee JD; Yoon PH; Kim EJ; Kim SH; Yoon YK
Yonsei Med J; 2001 Feb; 42(1):128-33. PubMed ID: 11293491
[TBL] [Abstract][Full Text] [Related]
12. A study of familial MELAS: evaluation of A3243G mutation, clinical phenotype, and magnetic resonance spectroscopy-monitored progression.
Chen C; Xiong N; Wang Y; Xiong J; Huang J; Zhang Z; Wang T
Neurol India; 2012; 60(1):86-9. PubMed ID: 22406788
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance spectroscopy: use in monitoring MELAS treatment.
Pavlakis SG; Kingsley PB; Kaplan GP; Stacpoole PW; O'Shea M; Lustbader D
Arch Neurol; 1998 Jun; 55(6):849-52. PubMed ID: 9626777
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial encephalomyopathy: elevated visual cortex lactate unresponsive to photic stimulation--a localized 1H-MRS study.
Kuwabara T; Watanabe H; Tanaka K; Tsuji S; Ohkubo M; Ito T; Sakai K; Yuasa T
Neurology; 1994 Mar; 44(3 Pt 1):557-9. PubMed ID: 8145933
[TBL] [Abstract][Full Text] [Related]
15. MERRF/MELAS overlap syndrome: a double pathogenic mutation in mitochondrial tRNA genes.
Nakamura M; Yabe I; Sudo A; Hosoki K; Yaguchi H; Saitoh S; Sasaki H
J Med Genet; 2010 Oct; 47(10):659-64. PubMed ID: 20610441
[TBL] [Abstract][Full Text] [Related]
16. Comparison of magnetic resonance spectroscopy (MRS) with arterial spin labeling (ASL) in the differentiation between mitochondrial encephalomyopathy, lactic Acidosis, plus stroke-like episodes (MELAS) and acute ischemic stroke (AIS).
Li X; Wang Y; Wang Z; Lu J; Xu Y; Ye J; Kuang Z; Li B; Pan M; Chen W; Lu S; Zhou Z; Cheng L; Wang H
J Clin Neurosci; 2018 Sep; 55():65-70. PubMed ID: 29921486
[TBL] [Abstract][Full Text] [Related]
17. [A case of incomplete Kearns-Sayre syndrome with a stroke like episode].
Furuya H; Sugimura T; Yamada T; Hayashi K; Kobayashi T
Rinsho Shinkeigaku; 1997 Aug; 37(8):680-4. PubMed ID: 9404143
[TBL] [Abstract][Full Text] [Related]
18. Cerebral lactic acidosis correlates with neurological impairment in MELAS.
Kaufmann P; Shungu DC; Sano MC; Jhung S; Engelstad K; Mitsis E; Mao X; Shanske S; Hirano M; DiMauro S; De Vivo DC
Neurology; 2004 Apr; 62(8):1297-302. PubMed ID: 15111665
[TBL] [Abstract][Full Text] [Related]
19. Brain MRS correlates with mitochondrial dysfunction biomarkers in MELAS-associated mtDNA mutations.
Gramegna LL; Evangelisti S; Di Vito L; La Morgia C; Maresca A; Caporali L; Amore G; Talozzi L; Bianchini C; Testa C; Manners DN; Cortesi I; Valentino ML; Liguori R; Carelli V; Tonon C; Lodi R
Ann Clin Transl Neurol; 2021 Jun; 8(6):1200-1211. PubMed ID: 33951347
[TBL] [Abstract][Full Text] [Related]
20. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.
Arnold DL; Riess GT; Matthews PM; Francis GS; Collins DL; Wolfson C; Antel JP
Ann Neurol; 1994 Jul; 36(1):76-82. PubMed ID: 8024266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
